Novartis (NVS) Tops Q4 EPS by 8c; Sees Lower Core Income in FY13

January 23, 2013 6:20 AM

Novartis (NYSE: NVS) reported Q4 EPS of $1.27, $0.08 better than the analyst estimate of $1.19. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found